✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Astellas Pharma Inc

Common Name
Astellas Pharma
Country
Japan
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
13,643
Ticker
4503
Exchange
TOKYO STOCK EXCHANGE
Description
Astellas Pharma Inc. is a prominent pharmaceutical company that engages in the research, development, manufacture, and marketing of pharmaceutical products across the globe. Headquartered in Japan, th...

Astellas Pharma's Climate Target Data Preview

As of 2025, Astellas Pharma has disclosed 5 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 4 absolute reduction targets and 1 intensity-based target, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Astellas Pharma's climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 3 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy/Paste is a PRO feature.
a
2030
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
0000000
2030
Absolute-based Target
Scope 3 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy/Paste is a PRO feature.
a
2050
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
0000000
2050
Intensity-based Target
Scope 3 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Japanese Yen (JPY) of Revenue
Copy/Paste is a PRO feature.
a
2030
Limited Data Preview
You are viewing a limited preview of Astellas Pharma’s Climate Target dataset. The full dataset, available for download, includes detailed baseline information for both absolute and intensity targets, along with reported progress and achievement details as of 2025.
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Astellas Pharma’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Astellas Pharma’s data sources below and access millions more through our Disclosure Search.

a. Astellas Pharma's Environmental Report 2025

Insights into Astellas Pharma's Greenhouse Gas Emissions Pathways

As of 2025, Astellas Pharma has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.a

Does Astellas Pharma have a target to reduce the emissions from its operations?

As of 2025, Astellas Pharma has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a

Astellas Pharma's most ambitious operational target is to reduce these emissions by 90% by 2050, compared to a baseline of 201,000 Metric Tonnes of CO2 equivalent (mtCO2e) in 2015.a

As of 2024, Astellas Pharma is ahead of schedule on its operational emissions reduction target, having achieved 51.41% of the planned reduction.a

Astellas Pharma's Operational (Scope 1+2) Emissions Pathway

2015202420302050055 k110 k165 k220 kBaselineCurrent (-46%)Target 2030 (-63%)Target 2050 (-90%)

Does Astellas Pharma have a target to reduce the emissions from its value chain?

As of 2025, Astellas Pharma has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol.a

Astellas Pharma's most ambitious value chain target is to reduce these emissions by 90% by 2050, compared to a baseline of 1,378,972 Metric Tonnes of CO2 equivalent (mtCO2e) in 2015.a

As of 2024, Astellas Pharma is lagging behind on its value chain emissions reduction target, having achieved 8.27% of the planned reduction.a

Astellas Pharma's Value Chain (Scope 3) Emissions Pathway

20152024203020500350 k700 k1.05 M1.4 MCurrent (-7%)Target 2030 (-37%)Target 2050 (-90%)
Want Full Access to Astellas Pharma's Climate Targets Dataset?
Sign Up